Accession Number: | 0001192482-19-000248 |
Date: | 2019-05-09 |
Issuer: | RECRO PHARMA, INC. (REPH) |
Original Submission Date: |
ASHTON WILLIAM
C/O RECRO PHARMA, INC.
490 LAPP ROAD
MALVERN, PA 19355
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2019-05-09 | A | 7,955 | a | $0.00 | 27,412 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 8.8 | 2019-05-09 | deemed execution date | A | 10,888 (a) | 2029-05-09 | common stock 10,888 | $8.80 | 10,888 | direct |
ID | footnote |
---|---|
f1 | all shares of common stock are represented by unvested restricted stock units that will vest on may 9, 2020. vested shares will be delivered to the reporting person within 30 days following the vesting date. |
f2 | the stock option will vest on may 9, 2020. |